pharmaceutical intermediates sourcing

Popular tags

Popular on the whole site

Conclusion


Once produced, APIs are typically combined with excipients to create a final pharmaceutical product. Excipients are inactive substances that serve as the vehicle for the API, aiding in drug formulation, stability, and delivery. The combination of API and excipients forms the final dosage form, such as tablets, capsules, or injectables.


China has emerged as a powerhouse in the production of APIs, accounting for a significant portion of global supply. One of the primary reasons for this remarkable growth is the country's vast manufacturing capabilities, which benefit from relatively low labor costs and substantial government investment in the pharmaceutical sector. As a result, many Western pharmaceutical companies have increasingly turned to China to source their APIs, leading to a dramatic increase in imports over the past decade.


The global API market is characterized by its robust growth trajectory, fueled by a combination of aging populations, growing awareness of health issues, and advances in drug development. As pharmaceutical companies continue to emphasize innovation and sustainability, the demand for high-quality APIs is at an all-time high. Moreover, the COVID-19 pandemic has amplified the need for a secure and reliable supply chain for APIs, underscoring their critical role in drug production.


Agricultural & sideline products

Conclusion


6. Considerations and Environmental Impact


Popular articles

Links